Skip to main content
SpringerLink
Log in
Book cover

International Medicines Regulations pp 135–148Cite as

Objectives and achievements of regulations in Japan

  • Chapter

  • 39 Accesses

Part of the book series: CMR Workshop Series ((CMRWS))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Worden A N and Roberts C N (1972). Experimental and Clinical Evaluations of Drugs and Drug Safety, Proceedings Japan — British Medical Symposium, Japan Medical Association, Tokyo 128–146

    Google Scholar 

  2. Takakura N (1987). Requirements for Pharmaceuticals and Medical Devices (Japan), Regulatory Affairs Professionals Society, November 19–20, San Francisco, USA

    Google Scholar 

  3. Shirota K (1986). Foreword, Pharmaceutical Administration in Japan, 3rd Edition, (Tokyo: Yakuji Nippo Ltd)

    Google Scholar 

  4. Roberts, C N (1980). GLP — The Management Viewpoint, Technical Seminar Text, British Medical Seminar, British Embassy, Tokyo

    Google Scholar 

  5. Roberts C N (1985a). Japan — regulations in the Land of the Rising Sun. BIRA J, 4 (1), 11–17

    Google Scholar 

  6. Roberts C N (1985b). International Aspects of GLP — the Japanese Situation, Proceedings of the Fourth International Meeting on Good Laboratory Practice, Cambridge, May 1985, pp. 53–72

    Google Scholar 

  7. Roberts C N (1986). Situations and predictions concerning Japan, Proceedings of 5th International Meeting on Good Laboratory Practice, Frankfurt, May 1986, pp. 176–198

    Google Scholar 

  8. Uchida K (1988). Acceptability of foreign clinical trial data in Japan. Drug Inf J, 22, 103–108

    Google Scholar 

Download references

Authors
  1. C. N. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Welsh School of Pharmacy, Cardiff, UK

    Stuart R. Walker (Director of the Centre for Medicines Research Carshalton, and Honorary Professor) (Director of the Centre for Medicines Research Carshalton, and Honorary Professor)

  2. The Association of the British Pharmaceutical Industry, London, UK

    John P. Griffin (Director, Professional Head of the Medicines Division) (Director, Professional Head of the Medicines Division)

  3. DHSS, London, UK

    John P. Griffin (Director, Professional Head of the Medicines Division) (Director, Professional Head of the Medicines Division)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Roberts, C.N. (1989). Objectives and achievements of regulations in Japan. In: Walker, S.R., Griffin, J.P. (eds) International Medicines Regulations. CMR Workshop Series. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0857-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0857-4_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6873-4

  • Online ISBN: 978-94-009-0857-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation